Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Domvanalimab by Arcus Biosciences for Non-Small Cell Lung Cancer: Likelihood of Approval
Domvanalimab is under clinical development by Arcus Biosciences and currently in Phase III for Non-Small Cell Lung Cancer. According to...
Domvanalimab by Arcus Biosciences for Recurrent Glioblastoma Multiforme (GBM): Likelihood of Approval
Domvanalimab is under clinical development by Arcus Biosciences and currently in Phase I for Recurrent Glioblastoma Multiforme (GBM). According to...
Domvanalimab by Arcus Biosciences for Glioblastoma Multiforme (GBM): Likelihood of Approval
Domvanalimab is under clinical development by Arcus Biosciences and currently in Phase I for Glioblastoma Multiforme (GBM). According to GlobalData,...